Wonderful | $34,000,000 | (Jul 4, 2025)
Argon AI | $5,500,000 | (Jul 4, 2025)
The Open Platform | $28,500,000 | (Jul 4, 2025)
Certified by Founder
Lodge
Bryleos
start up
United States
- Johnson City, Tennessee
- 14/06/2023
- Seed
- $5,000,000
Early clinical stage therapeutics company developing BNAD101, a patent-pending oral composition of NAD+ clinically proven to increase intracellular NAD+. BNAD101 is a potential high-value medicine to treat challenging and costly neurological disorders.
In 2022, the Company completed its double-blind, placebo-controlled proof of concept study at the Institute of Systems Biology. The study of 60 healthy adults demonstrated BNAD101 had a 52% increase in intracellular NAD levels against placebo within just 5 days, effectively validating the potential of BNAD101 in treating not only chronic neurological conditions but conditions were swift response is critical.
Bryleos: More Life While Living
- Industry Biotechnology Research
- Website https://bryleos.com/
- LinkedIn https://www.linkedin.com/company/bryleos/
CIMware | $2,300,000 | (Jul 4, 2025)
FitFeast (As Seen on Shark Tank) | $643,286 | (Jul 4, 2025)
Yaspa | $12,000,000 | (Jul 4, 2025)
Nautica Technologies | $3,999,764 | (Jul 4, 2025)
Luma fertility | $4,000,000 | (Jul 4, 2025)
Circulate | $12,000,000 | (Jul 4, 2025)
AssetCool | $13,648,243 | (Jul 4, 2025)
Vok Bikes | $6,000,000 | (Jul 4, 2025)
MediShout | $9,000,000 | (Jul 4, 2025)